WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997035587) COMPOSITIONS COMPRISING AN HIV PROTEASE INHIBITOR SUCH AS VX 478 AND A WATER SOLUBLE VITAMIN E COMPOUND SUCH AS VITAMIN E-TPGS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/035587    International Application No.:    PCT/EP1997/001438
Publication Date: 02.10.1997 International Filing Date: 21.03.1997
Chapter 2 Demand Filed:    06.10.1997    
IPC:
A61K 9/48 (2006.01), A61K 31/425 (2006.01), A61K 31/495 (2006.01), A61K 31/535 (2006.01), A61K 31/635 (2006.01), A61K 47/22 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (For All Designated States Except US).
ROY, Arup, K. [US/US]; (US) (For US Only).
TILLMAN, Lloyd, Gary [US/US]; (US) (For US Only)
Inventors: ROY, Arup, K.; (US).
TILLMAN, Lloyd, Gary; (US)
Agent: QUILLIN, Helen, K.; Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB)
Priority Data:
60/013,893 22.03.1996 US
9606372.2 26.03.1996 GB
  20.03.1997 US
Title (EN) COMPOSITIONS COMPRISING AN HIV PROTEASE INHIBITOR SUCH AS VX 478 AND A WATER SOLUBLE VITAMIN E COMPOUND SUCH AS VITAMIN E-TPGS
(FR) COMPOSITIONS CONTENANT UN INHIBITEUR DE LA PROTEASE DU VIH TEL QUE LE VX 478 ET UN COMPOSE HYDROSOLUBLE DE VITAMINE E TEL QUE LA VITAMINE E-TPGS
Abstract: front page image
(EN)Pharmaceutical formulations containing HIV protease inhibitors, specifically including 3S-[3R*(1R*,2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (alternatively known as VX 478 or 141W94), and a tocopherol, and their use in medical therapy are described.
(FR)L'invention porte sur des préparations pharmaceutiques contenant des inhibiteurs de la protéase du VIH comportant en particulier un tétrahydro-3-furanyl ester de l'acide 3S-[3R*(1R*,2S*)]-[3-[[(4-aminophényl)sulphonyl](2-méthylpropyl)-amino]-2-hydroxy-1-phénylméthyl)propyl] carbamique (également dénommé VX 478 ou 141W94) ainsi qu'un tocophérol, et sur leur emploi à des fins thérapeutiques.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)